| RCUS Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RCUS shares outstanding history going back to 3/15/2018:
Also see: RCUS Market Cap History RCUS YTD Return |
RCUS Shares Outstanding History — Arcus Biosciences Share Count Over Time
As of 4/30/2026 Arcus Biosciences has 125.77 million RCUS shares outstanding. Investors often track the RCUS shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows RCUS share count trends over time, with 33 historical shares outstanding datapoints presented, dating back to 3/15/2018.
| RCUS Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RCUS Historical Shares Outstanding: +14.56% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RCUS Stock Price Chart |
| About Arcus Biosciences Inc |
| Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. Co. involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. Co. has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. We show 33 historical shares outstanding datapoints in our coverage of RCUS's shares outstanding history. Understanding the changing numbers of RCUS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like RCUS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching RCUS by allowing them to research RCUS shares outstanding history as well as any other stock in our coverage universe. |
| RCUS Current Stock Quote |
Quotes delayed 20 minutes  Free RCUS Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| RCUS Share Performance |
| Shares Outstanding Peers |
| Arcus Biosciences (RCUS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RDHL Shares Outstanding History RDNT Shares Outstanding History RDY Shares Outstanding History REGN Shares Outstanding History RENB Shares Outstanding History REPH Shares Outstanding History REPL Shares Outstanding History REPR Shares Outstanding History RETA Shares Outstanding History REXN Shares Outstanding History More Healthcare companies » |
RCUS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
